VVMD-VAC

Country: New Zealand

Language: English

Source: Ministry for Primary Industries

Active ingredient:

turkey herpes virus (attenuated); marek's disease virus (attenuated)

Available from:

Pacificvet Limited

INN (International Name):

marek's disease virus (attenuated), turkey herpes virus (attenuated)

Composition:

turkey herpes virus (attenuated) 0 vaccine; marek's disease virus (attenuated) 0 vaccine

Therapeutic area:

Vaccine

Authorization status:

ACVM Registered

Authorization date:

1993-05-31

Summary of Product characteristics

FOR ANIMAL TREATMENT ONLY
SEE WWW.FOODSAFETY.GOVT.NZ
FOR REGISTRATION CONDITIONS
STERILE DILUENT
REGISTERED PURSUANT TO THE ACVM ACT
1997 NO. A2733, A6751, A7892, A11274
MANUFACTURER RECOMMENDS A
WITHDRAWAL PERIOD OF 21 DAYS.
REGISTERED TO:
3 HICKORY PLACE, PO BOX 16-129,
HORNBY, CHRISTCHURCH
NEW ZEALAND
TEL: [phone]
33801
For use with Zoetis Marek’s Disease Vaccines for chickens.
Registered pursuant to the ACVM Act 1997 No A2733, A6751,
A7892, A11274.
Manufacturer recommends a withdrawal period of 21 days.
Ingredients: NZ Amine, Sucrose, inert ingredients and water.
Caution: Store at room temperature. Avoid freezing or
excessive temperatures of 40°C or above.
This product is non-returnable.
For Animal Treatment Only
See www.foodsafety.co.nz
For registration conditions
400 bag
400 mL
STERILE DILUENT
Manufactured by Zoetis Inc
Kalamazoo MI 49007 USA
Registered to Pacificvet Limited
3 Hickory Place, PO Box 16-129,
Hornby, Christchurch,
New Zealand Tel: [phone]
34002
MAREK’S DISEASE VACCINE
SEROTYPES 2 & 3, LIVE VIRUS
VVMD-VAC™
USE ENTIRE CONTENTS. BURN THIS VIAL. SEE
INSERT. MFG BY-M/S ZOETIS, INC., 2000
ROCKFORD ROAD, CHARLES CITY, IOWA, USA.
IMPORTED BY-M/S ZOETIS INDIA LIMITED,
-BHIWANDI, THANE, IMPORT LICENSE NO-
SVV-9-13. U.S. VET. LIC. NO. 190.
MRP(RS)INCLUSIVE OF TAXES-3055.00
40020417
SERIALNO.
EXP. DATE
1,000 DOSES
Wording is etched on
the glass ampule
(actual size)
5 x ampules to a cane
DIRECTIONS
Use only the Sterile Diluent
supplied with the product
to reconstitute the
vaccine.
Store diluent at less than 27
°
C.
Wear protective clothing and equipment when withdrawing the vaccine
from
the Liquid Nitrogen flask,
protect
hands with gloves,
wear
long sleeves,
overalls, closed in footwear, and use a face mask or goggles.
Prior to removing the vaccine ampoule from the liquid nitrogen flask
prepare
a water bath to thaw the vaccine.
A container capable of holding 5 litres of
warm water at 27
°
C is ideal.
When withdrawing a cane of
ampoules from the liquid nitrogen flask,
avoid
exposing amp